Why Transmedics Group Stock Plummeted 21% This Week

Shares of Transmedics Group (NASDAQ: TMDX) sank over 20% this week, according to data from S&P Global Market Intelligence. The organ transplant disrupter announced a CFO transition and reduced the range for its full-year 2024 guidance, indicating slowing revenue growth. As of 1:54 p.m. ET on Friday, Dec. 6, Transmedics stock is down 60% from all-time highs set just earlier this summer.Here's why Transmedics Group stock has been falling once again.On Dec. 2, Transmedics announced that its CFO, Stephen Gordon, would be retiring and that Gerardo Hernandez would take over the position. Investors typically do not like it when CFOs leave, which could be why Transmedics stock is falling this week. However, Hernandez looks like an experienced person for the role, with 25 years in the healthcare and consumer packaged goods sectors.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool